Close Menu

Integrated Diagnostics



Albert Luderer

Paired Ends


Jay Therrien, Evan Eichler, Avak Kahvejian, Leroy Hood, David Galas

The firm, called Integrated Diagnostics, will validate existing biomarkers and develop assays for them using MRM and proprietary technologies. It expects to launch its first test in about four years.

Integrated Dx will make use Hood's research into protein blood markers, which can provide physiological data on the body's 50 major organs. Using genomic and proteomic techniques, Hood and his research team at ISB will be able to detect protein blood markers in a specific organ site to gain insight into disease states and treatment response.

Leroy Hood's new firm, Integrated Diagnostics, has received $30 million in Series A funding.


Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.